【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 10
1.2 List of Figures 10
2 Diabetes Therapeutics Market in India to 2018 – Overview 11
2.1 Diabetes Mellitus – A Global Overview 11
3 Diabetes Therapeutics Market in India – Introduction 12
3.1 Type 1 Diabetes Mellitus 12
3.1.1 People at Risk 12
3.1.2 Risk Factors for Type 1 Diabetes 12
3.1.3 Symptoms 12
3.2 Type 2 Diabetes Mellitus 13
3.2.1 People at Risk 13
3.2.2 Risk Factors for Type 2 Diabetes 13
3.2.3 Symptoms 13
3.3 Gestational Diabetes Mellitus 13
3.3.1 Risk Factors for Gestational Diabetes Mellitus 13
3.4 Diagnosis of Diabetes Mellitus 14
3.5 Diabetes Treatment Guidelines – India 15
3.5.1 Introduction 15
3.5.2 Prevention of Diabetes 15
3.5.3 Diabetes Treatment 15
3.6 Diabetes Mellitus Complications 16
4 Diabetes Therapeutics Market in India to 2018 – Major Drug Classes 17
4.1 Sulfonylureas 17
4.1.1 Introduction 17
4.1.2 Mechanism of Action 17
4.1.3 Major Drugs 18
4.2 Thiazolidinediones 18
4.2.1 Introduction 18
4.2.2 Mechanism of Action 18
4.2.3 Example 18
4.3 Biguanides 19
4.3.1 Introduction 19
4.3.2 Mechanism of Action 19
4.3.3 Drug Products 19
4.4 Meglitinides 20
4.4.1 Introduction 20
4.4.2 Mechanism of Action 20
4.4.3 Major Drugs 20
4.5 Alpha-Glucosidase Inhibitors 21
4.5.1 Introduction 21
4.5.2 Mechanism of Action 21
4.5.3 Major Drugs 21
4.6 Glucagon-Like Peptide Analogs and Agonists 22
4.6.1 Description 22
4.6.2 Mechanism of Action 22
4.6.3 Major Drugs 22
4.7 Dipeptidyl Peptidase-4 Inhibitors 22
4.7.1 Description 22
4.7.2 Mechanism of Action 22
4.7.3 Major Drugs 23
4.8 Glucagon-Like Peptide-1 Analogs vs. Dipeptidyl Peptidase-4 Inhibitors 23
4.9 Insulin Preparations 23
4.9.1 Introduction 23
4.9.2 Types of Insulin 23
5 Diabetes Therapeutics Market in India to 2018 – Epidemiology 25
5.1 Introduction 25
5.2 Diabetes Population in India 27
5.3 Diagnosed Population 29
5.4 Treated Population 29
6 Diabetes Therapeutics Market in India to 2018 – Revenue Forecasts 30
6.1 Introduction 30
6.1.1 Oral Anti-Diabetics Market 31
6.1.2 Insulin Market 31
6.2 Annual Cost of Therapy 32
7 Diabetes Therapeutics Market in India to 2018 – Economic Burden of Diabetes in India 33
7.1 Economic Burden of Diabetes in India 33
7.1.1 Introduction 33
7.1.2 Healthcare Expenditure on Diabetes in India 33
7.2 Collaborative Efforts Necessary to Address the Rising Burden of Diabetes 34
8 Diabetes Therapeutics Market in India to 2018 – Drivers and Barriers 35
8.1 Market Drivers 35
8.1.1 Aging Population, Sedentary Lifestyle and Unhealthy Diet is Driving the Diabetic Population in India 35
8.1.2 Promising Molecules Offering Improved Clinical Outcomes Could Increase Patient Base on Therapy 35
8.1.3 Untapped Areas Offer Promising Opportunities to Pharmaceutical Companies 36
8.2 Market Barriers 36
8.2.1 Low Diagnosis and Prescription Rate 36
8.2.2 Highly Competitive Market Driven by Generics and Branded Generics Increases Pricing Pressure 36
8.2.3 High Out-of-Pocket and Low Healthcare Expenditure on Diabetes 37
9 Diabetes Therapeutics Market in India to 2018 – Unmet Needs 38
9.1 Introduction 38
9.2 High Cost of Therapy and Drug Safety Issues Affect Patient Compliance 38
9.3 Unmet Need Creates Opportunities for Pharmaceutical Companies 38
10 Diabetes Therapeutics Market in India to 2018 – Product Pipeline Analysis 39
10.1 Profiles of Promising Molecules in R&D Development 40
10.1.1 IN-105 (Oral Insulin) 40
10.1.2 NN9068/IDegLira/degludec +/- liraglutide 40
10.1.3 Dapagliflozin 41
10.1.4 Canagliflozin/TA-7284 42
10.1.5 Lixisenatide 42
10.1.6 Alogliptin 42
11 Diabetes Therapeutics Market in India to 2018 – Case Studies 43
11.1 Avandia Fallout Impact 43
11.1.1 Introduction 43
11.1.2 Cardiovascular Safety Issues 43
11.1.3 Impact on GlaxoSmithKline 43
11.1.4 Impact on Drug Approvals 43
11.2 Januvia from Merck an Example that Patented Products can succeed in India 44
11.2.1 Introduction 44
11.2.2 Improved Pharmacological Effect of DPP-4 Inhibitors Helped Rapid Adoption 44
11.2.3 Januvia and Janumet a New Growth Engine for Merck 44
11.2.4 Robust Approach Needed to Market a New Drug Product in India 44
11.2.5 Excellent Commercialization Strategy 45
11.2.6 Conclusion 45
12 Diabetes Therapeutics Market in India to 2018 – Major Trends and Issues 46
12.1 Biguanides Class is dominated by Generics 46
12.2 Evolving Oral Hypoglycemic Agents Resulting in Smaller Market Share Sulfonylureas 46
12.3 Increasing Competition in Dipeptidyl Peptidase-4 Inhibitor Class 46
12.3.1 DPP-4 Inhibitors Likely to Face Potential Competition from GLP-1 Agonists 46
12.4 Thiazolidinedione Class to Face Impact of Avandia Fallout 47
12.5 GLP-1 Agonists Must Demonstrate Better Safety and Efficacy Profiles to Compete with other Oral Hypoglycemic Class 47
12.6 Fierce Competition in the Insulin Market is Likely to Increase 48
12.7 Is Oral Insulin the Next Big Thing in the Insulin Market? 48
12.7.1 Introduction 48
12.7.2 Oral Insulin Not for All 48
12.7.3 Challenges to Overcome 48
12.7.4 Would it lead to Market Cannibalization? 49
12.8 India Diabetes Market: Setting up for the Biosimilars? 49
12.8.1 Introduction 49
12.8.2 Insulin Biosimilar Market 49
12.8.3 Sanofi’s Lantus a Lucrative Target 49
12.8.4 Need for Dose Adjustments would Discourage Uptake of Biosimilars 50
12.8.5 Price Discounts Alone would be Insufficient 50
12.8.6 Strong Brand Promotion would be Necessary for Insulin Biosimilars 50
12.8.7 Collaborations and Licensing Agreements are Key 50
12.8.8 Conclusion 51
12.9 Sodium Glucose Co-Transporter2 Inhibitors: A New Class to Hit the Market? 51
12.10 Glucokinase Activators 51
12.11 Stem Cell Therapies: The Next Prospective Therapy for Diabetes? 52
12.11.1 Introduction 52
12.11.2 What are Stem Cells? 52
12.11.3 Stem Cell Therapies and Diabetes 52
12.11.4 Conclusion 52
12.12 Price Discounts a Decisive Factor in the Increasingly Competitive Anti-Diabetes Market 53
12.13 Favorable Government Polices to Promote Generics 53
12.14 Strategic Consolidation to Increase Growth Prospects 54
12.14.1 Introduction 54
12.14.2 Shift of Focus towards Rural and Class II-IV Towns 54
13 Diabetes Therapeutics Market in India to 2018 – Competitive Landscape 55
13.1 Novartis India Limited (Novartis India) 55
13.2 Novo Nordisk India Private Limited (Novo) 56
13.3 Eli Lilly and Company (India) Pvt. Ltd. (Eli Lilly) 57
13.4 Merck Sharp Dohme India 57
13.5 Abbott India Limited (Abbott India) 58
13.6 Sun Pharmaceutical Industries Limited (Sun Pharma) 59
13.7 USV Limited 60
13.8 Wockhardt Limited (Wockhardt) 61
13.9 Sanofi India Limited 62
13.10 Biocon Limited (Biocon) 63
14 Diabetes Therapeutics Market in India to 2018 – Strategic Consolidations 64
14.1 Introduction 64
14.2 Diabetology Entered into Licensing Agreement with USV for Capsulin on July 31, 2012 64
14.3 Merck Sharp & Dohme Entered into Co-Marketing Agreement with Sun Pharma on April 25, 2011 64
14.4 Eli Lilly and Company (India) Entered into Co-Promotion Agreement with Lupin on July 29, 2011 65
14.5 Sheffield Bio-Science Entered into Collaboration with Wockhardt on February 21, 2011 65
14.6 Eli Lilly Entered into Co-Promotion Agreement with Boehringer Ingelheim for Humalog and Linagliptin on October 3, 2011 65
14.7 Novartis India Entered into Co-Marketing Agreement with USV on December 31, 2008 65
14.8 Pfizer-Biocon Deal Called Off in March 2012 66
14.8.1 Impact Analysis 66
15 Diabetes Therapeutics Market in India to 2018 – Appendix 67
15.1 Market Definitions 67
15.2 Abbreviations 67
15.3 Bibliography 68
15.4 Research Methodology 69
15.4.1 Coverage 69
15.4.2 Secondary Research 70
15.4.3 Primary Research 70
15.5 Therapeutic Landscape 71
15.5.1 Market 73
15.6 Geographical Landscape 74
15.7 Pipeline Analysis 74
15.8 Competitive Landscape 74
15.8.1 Expert Panel Validation 74
15.9 Contact Us 74
15.10 Disclaimer 74
【レポート販売概要】
■ タイトル:Diabetes Therapeutics Market in India to 2018 – Rapid Uptake of DPP-IV Inhibitors, GLP-1 Agonists and Expanding Insulin Segment to Drive Growth■ 発行日:2013年1月22日
■ 調査会社:GBI Research
■ 商品コード:GBIR403170005
■ 調査対象地域:インド
- イランの発電市場2016:市場動向、制度、競争状況Iran Power Market Outlook to 2030, Update 2016 - Market Trends, Regulations and Competitive Landscape Summary This report elaborates Iran's power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the Iran power market’s regulatory structure, import and export trends, competitive landscape, and power projects at v …
- 実験室備品の世界市場:ラベルプリンター、ピペットチップ、マイクロプレート、試薬リザーバー、バルブ、チューブ、洗浄ステーションThe dearth of qualified laboratory professionals (over 17% of laboratory professionals are set to retire in the next five years) and rising aging population have increased the demand for laboratory automation. The application of advanced technology in testing laboratories has gained importance as it ensures timely progress and efficiency with minimal errors. This has led to the adoption of lab aut …
- 群知能(SI)の世界市場予測(~2030年)The swarm intelligence market is expected to be valued at USD 447.2 Million by 2030, growing at a CAGR of 40.47% from 2020 to 2030, considering the technology will get commercialized by 2020. The major factors driving the growth of this market include the increasing usage of swarm intelligence for solving big data problems and the rising adoption of swarm-based drones in the military. In transport …
- 通年性アレルギー性鼻炎(Perennial Allergic Rhinitis):世界の治験レビュー2014年下半期版Perennial Allergic Rhinitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Perennial Allergic Rhinitis Global Clinical Trials Review, H2, 2014" provides data on the Perennial Allergic Rhinitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Perennial Allergic Rhinitis. It includes an overview of t …
- マッサージ機の世界市場2017-2021About Massage Equipment Massagers are primarily prevalent in the market based on their massage mechanisms such as natural, organic, acupressure, shiatsu, ultrasonic, hypoallergic, homeopathic, and aromatherapy. Inexpensive electric massagers attract much of the end-users in developing countries. Countries like the US and the UK are the major revenue contributors to the global massage equipment mar …
- グライコミクス/糖鎖生物学の世界市場分析:製品別(酵素、キット、試薬、機器)、用途別(創薬および開発、診断)、エンドユーザー別、セグメント予測、2014-2025The global glycomics/glycobiology market is expected to reach USD 2.1 billion by 2025, according to a new report by Grand View Research, Inc. Increasing investment in R&D by research institutes and pharmaceutical & biotechnology companies has been a major factor driving market growth. In addition, technological advancement has led to increased demand for advanced glycomics products for drug discov …
- 冷蔵・冷凍倉庫の世界市場予測(~2022年):噴射冷却、蒸気圧縮、PLC、気化冷却The refrigerated warehousing market is projected to grow at a CAGR of 10.2% from 2017, to reach a value of USD 29.17 Billion by 2022. The global demand for refrigerated warehousing is increasing significantly due to the growing demand for frozen food products such as fish, meat, and seafood, leading to a rise in the requirement for refrigerated storage for these perishable foods. Growing health-co …
- ビタミンD試験の世界市場分析:試験タイプ別(25-ヒドロキシビタミンD試験; 1,25-ジヒドロキシビタミンD試験)、地域別(北アメリカ、ヨーロッパ、アジア太平洋、中南米、MEA)、セグメント予測、2014-2025The global vitamin D testing market is expected to reach USD 1.1 billion by 2025, according to a new report by Grand View Research, Inc. Global increase in geriatric population as well as cases of chronic illnesses is likely to drive the market during the forecast period. Furthermore, increase in investment for development and commercialization of various accurate, innovative, and easy-to-use test …
- 世界の空港手荷物搬送設備市場(2013 – 2020)This report presents a complete market study of the global commercial airport baggage handling system (BHS) market from 2013 to 2020. It also provides the factors that drive the market, the challenges the market face, and the restraints that impact the growth of the baggage handling process market and its industry. The factors that affect the baggage handling system market are terminal expansions, …
- 世界の超音波探傷検査装置市場(2014-2018)About Ultrasonic Testing Equipment Ultrasonic testing is a type of non-destructive testing (NDT). NDT is a method of finding discontinuity in test material without harming the material. Ultrasonic testing equipment uses high-frequency sound energy to conduct examinations and make measurements. The frequency used for ultrasonic testing is in the range of 500 KHz to 20 MHz. Ultrasonic testing equipm …
- タンブラーの世界市場展望2017-2026According to Stratistics MRC, the Global Tumblers Market is accounted for $2.10 billion in 2017 and is expected to reach $4.19 billion by 2026 growing at a CAGR of 8.0% during the forecast period. The increasing beverage industry, on-the-go drinkware, increasing outdoor activities, and growing health & fitness concerns are some of the factors fuelling market growth. However, the cost of tumblers c …
- 世界の先端相変化物質市場Energy saving, environment friendliness, and wide range of applications are the main growth driver for PCM market. It offers applications across building & construction, HVAC, textile, fixed refrigeration, cold chain, thermal energy storage, electronics, and more. Building & construction has the largest PCM market followed by HVAC. The global PCM market is estimated to grow from $460 million in 20 …
- ソフトスキルトレーニングの世界市場2016-2020About Soft Skills TrainingSoft skills can be broadly categorized under three segments: character, interpersonal skills, and critical and creative thinking. Soft skills play a crucial role in enabling individuals to communicate effectively, manage a team with good interpersonal skills, and solve problems. Therefore, apart from training students and employees in technical skills, organizations and e …
- ワクチンの世界市場:サブユニットワクチン、弱毒生ワクチン、結合型ワクチン、不活化ワクチン、 組換え型ワクチン、トキソイドワクチン等The vaccines market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%. The global vaccines market is categorized on the basis of type, technology, disease indication, end user, and geography. The preventive vaccines segment is expected to register the highest growth rate in the vaccines market, by type, during the forecast period. Its favorable growt …
- 世界の緑内障治療市場動向(2014-2018)About Glaucoma Therapeutics Glaucoma is a disease of the eye in which fluid pressure within the eye increases. If left untreated the patient may lose vision and even become blind. The exact etiology of optic nerve damage due to glaucoma is not fully known, but involves mechanical compression and/or decreased blood flow in the optic nerve. Based on whether the cause of the disease is unknown or kno …